Published in
Elsevier, Lancet Haematology, 6(7), p. e447-e455, 2020
DOI: 10.1016/s2352-3026(20)30081-8
Links
Tools
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials
Journal article published in 2020 by
Saad Z. Usmani,
Hareth Nahi 
,
Torben Plesner,
Brendan M. Weiss,
Nizar J. Bahlis,
Andrew Belch,
Peter M. Voorhees,
Jacob P. Laubach,
Niels W. C. J. van de Donk,
Tahamtan Ahmadi,
Clarissa M. Uhlar,
Jianping Wang,
Huaibao Feng,
Ming Qi,
Paul G. Richardson
and other authors.
,
Torben Plesner,
Brendan M. Weiss,
Nizar J. Bahlis,
Andrew Belch,
Peter M. Voorhees,
Jacob P. Laubach,
Niels W. C. J. van de Donk,
Tahamtan Ahmadi,
Clarissa M. Uhlar,
Jianping Wang,
Huaibao Feng,
Ming Qi,
Paul G. Richardson
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 